Clinical Trial Update: Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma [NA]

View source ↗

Summary

A clinical trial is evaluating SAMe (S-adenosylmethionine) for preventing recurrence after radical treatment of hepatocellular carcinoma; the current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SAMe (S-adenosyl-L-methionine)

Snippet

Sponsor: Beijing Insight Science & Technology Co. Ltd. | Conditions: Primary Liver Cancer | NA | Status: UNKNOWN